| Literature DB >> 29797432 |
Shaohua Hu1, Lin Cao2, Yiyin Wu3, Yajun Zhou2, Tao Jiang2, Liqiang Wang2, Qiujing Wang4, Desong Ming5, Shicheng Chen6, Mingxi Wang2.
Abstract
Myroides odoratimimus is an important nosocomial pathogen. Management of M. odoratimimus infection is difficult owing to the multidrug resistance and the unknown pathogenesis mechanisms. Based on our previous genomic sequencing data of M. odoratimimus PR63039 (isolated from a patient with the urinary tract infection), in this study, we further performed comparative genomic analysis for 10 selected Myroides strains. Our results showed that these Myroides genome contexts were very similar and phylogenetically related. Various prophages were identified in the four clinical isolate genomes, which possibly contributed to the genome evolution among the Myroides strains. CRISPR elements were only detected in the two clinical (PR63039 and CCUG10230) isolates and two environmental (CCUG12700 and H1bi) strains. With more stringent cutoff parameters in CARD analysis, the four clinical M. odoratimimus contained roughly equal antibiotic resistance genes, indicating their similar antibiotic resistance profiles. The three clinical (CCUG10230, CCUG12901, CIP101113) and three environmental (CCUG12700, L41, H1bi) M. odoratimimus strains were speculated to carry the indistinguishable virulent factors (VFs), which may involve in the similar pathogenesis mechanism. Moreover, some VFs might confer to the high capacity of dissemination, attacking tissue cells and induction of autoimmune complications. Our results facilitate the research of antibiotic resistance and the development of therapeutic regimens for the M. odoratimimus infections.Entities:
Keywords: zzm321990Myroides odoratimimuszzm321990; antibiotic resistance genes; comparative genomics; virulence factors
Mesh:
Substances:
Year: 2018 PMID: 29797432 PMCID: PMC6391281 DOI: 10.1002/mbo3.634
Source DB: PubMed Journal: Microbiologyopen ISSN: 2045-8827 Impact factor: 3.139
General genomic characteristics of 10 Myroides strains
| Sources | Strain | Site of isolation | Type | Assembly No. | Level | Scaffold | Size (Mb) | GC (%) | Gene | Protein | rRNA | tRNA | Other RNA | Pseudo gene |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinically pathogenic | PR63039 | Urine | GCA_001481655.1 | 2 | 4.46 | 34.14 | 4,084 | 3,840 | 27 | 105 | 4 | 108 | ||
| Chr | NZ_CP013690.1 | Complete | 4.37 | 34.20 | 3,988 | 3,745 | 27 | 105 | 4 | 107 | ||||
| Plsm | NZ_CP013691.1 | 0.09 | 31.30 | 96 | 95 | ‐ | ‐ | ‐ | 1 | |||||
| CCUG 10230 | Skin wound | Chr | GCA_000242075.2 | Scaffold | 7 | 4.03 | 34.10 | 3,610 | 3,458 | 5 | 76 | 4 | 67 | |
| CCUG 12901 | Urogenital tract | Chr | GCA_000242095.1 | Scaffold | 3 | 4.07 | 34.20 | 3,653 | 3,505 | 9 | 75 | 4 | 60 | |
| CIP 101113 | Skin wound | Chr | GCA_000242135.1 | Scaffold | 3 | 4.14 | 34.10 | 3,673 | 3,516 | 8 | 71 | 4 | 74 | |
| Environmental | CCUG 3837 | N/A | Chr | GCA_000297855.1 | Scaffold | 4 | 4.14 | 34.40 | 3,611 | 3,459 | 11 | 72 | 4 | 65 |
| CCUG 12700 | N/A | Chr | GCA_000413415.1 | Scaffold | 7 | 4.04 | 34.30 | 3,581 | 3,423 | 7 | 87 | 4 | 60 | |
| H1bi |
| Chr | GCA_000633375.1 | Contig | 183 | 3.88 | 34.00 | 3,549 | 3,260 | 4 | 85 | 4 | 196 | |
| L41 | Lake water | Chr | GCA_000812825.1 | Contig | 168 | 4.16 | 33.60 | 3,802 | 3,599 | 82 | 4 | 114 | ||
| Human‐associated | CCUG 39352 | Wound | Chr | GCA_001485415.1 | Contig | 65 | 4.24 | 33.90 | 3,789 | 3,650 | 74 | ‐ | ‐ | |
|
| Urethral catheter | Chr | GCA_000807225.1 | Complete | 1 | 4.16 | 34.10 | 3,750 | 3,554 | 24 | 101 | 4 | 67 |
Chr, chromosome; Plsm, plasmid; N/A, not available.
The softwares and databases used for comparative analysis
| Analysis | Software/database | References | Clinically pathogenic strains | Environmental strains | Human‐associated strains | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PR63039 | CCUG 10230 | CCUG 12901 | CIP 101113 | CCUG 12700 | L41 | H1bi | CCUG 3837 | CCUG 39352 |
| |||
| Sequence level | Complete | Scaffold | Scaffold | Scaffold | Scaffold | Contig | Contig | Scaffold | Contig | Complete | ||
| Phylogenetic tree | REALPHY | Bertels, Silander, Pachkov, Rainey, & van Nimwegen, | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| CG | CG viewer | Grant & Stothard, | Yes | Yes | Yes | Yes | ||||||
| ISs | IS Finder | Siguier, Perochon, Lestrade, Mahillon, & Chandler, | Yes (43) | Yes (169) | Yes (117) | Yes (104) | ||||||
| Synteny | Progressive mauve | Darling et al., | Yes | Yes | Yes | Yes | Yes | Yes | Yes | |||
| Prophage | PHAST | Zhou, Liang, Lynch, Dennis, & Wishart, | Yes (2 incomplete) | Yes (2) | Yes (5) | Yes (1) | ||||||
| CRISPR | CRISPR Finder | Bland et al., | Yes (3) | Yes (4) | Yes (ND) | Yes (ND) | Yes (1) | Yes (ND) | Yes (1) | |||
| Antibiotic resistance genes | CARD Resistance Gene identifier | Mcarthur et al., | Yes | Yes | Yes | Yes | ||||||
| Virulence factors | VFDB protein Set B database | Chen et al., | Yes | Yes | Yes | Yes | Yes | Yes | ||||
CG, Circular genome maps (Genomic variants); ISs, insertion sequence elements; Yes, analyzed; (): number of the predicted; ND, not detected.
Figure 1Whole‐genome phylogenetic tree of 10 Myroides isolates. This Whole‐genome phylogenetic tree was produced by REALPHY with the default parameters. Strain L41 was used as the root
Figure 2Genomic comparisons in four clinically pathogenic M. odoratimimus strains. Blast 1: CCUG10230. Blast 2: M. CCUG12901. Blast 3: CIP101113. The contents of the feature rings (starting with the outermost ring) are as follows: Ring 1: forward strand features the read from the primary sequence of PR63039. Rings 2: forward strand ORFs from the primary sequence of PR63039. Rings 3: reverse strand ORFs from the primary sequence of PR63039. Ring 4: reverse strand features read from the primary sequence of PR63039. Ring 5 (vermilion): blast 1. Ring 6 (green): blast 2. Ring 7 (blue): blast 3. Ring 8 (black): the G + C content. Ring 9 (green and purple): the GC skew value
Figure 3Prophage regions and predicted elements in three clinically pathogenic M. odoratimimus strains. Different colored rectangles indicated different phage elements. Att, attachment site; Hyp, hypothetical protein; PLP, Other phage‐like protein; sha, Tail shaft; Pro, protease; Tra, transposase
The predicted resistance genes in the genomes of four clinically pathogenic M. odoratimimus strains
| Category | PR63039 | CCUG12901 | CCUG10230 | CIP101113 |
|---|---|---|---|---|
| Efflux pump complex or subunit conferring antibiotic resistance |
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
| Determinant of elfamycin resistance |
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
| Determinant of phenicol resistance |
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
| Determinant of diaminopyrimidine resistance |
|
|
|
|
| Determinant of triclosan resistance |
|
|
|
|
| Antibiotic inactivation enzyme |
|
|
|
|
|
|
|
| ||
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
| ||||
|
|
|
|
| |
| Antibiotic target replacement protein |
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
| Determinant of fluoroquinolone resistance |
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
| Determinant of beta‐lactam resistance |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
‐not predicted
The VFs predicted in three clinically pathogenic and three environmental M. odoratimimus genomes
| Classification | Definition | Genes coding for virulence factors | |||||
|---|---|---|---|---|---|---|---|
| Clinically pathogenic | Environmental | ||||||
| CCUG. 12901 | CCUG. 10230 | CIP. 101113 | H1bi | L41 | CCUG. 12700 | ||
| Capsular polysaccharide | UDP‐N‐acetyl‐D‐galactosamine 6‐dehydrogenase |
|
|
|
|
|
|
| UDP‐glucose 4‐epimerase |
|
|
|
|
|
| |
| Bifunctional UDP‐N‐acetylglucosamine pyrophosphorylase/glucosamine‐1‐phosphate N‐acetyltransferase |
|
|
|
|
|
| |
| UDP‐glucose 6‐dehydrogenase |
|
|
|
|
|
| |
| Capsule sialic acid | UDP‐N‐acetylglucosamine 2‐epimerase |
|
|
|
|
|
|
| Cell wall Peptidoglycan | Undecaprenyl diphosphate synthase |
|
|
|
|
|
|
| Glucose‐1‐phosphate thymidylytransferase |
|
|
|
|
|
| |
| dTDP‐glucose 4,6‐dehydratase |
|
|
|
|
|
| |
| UDP‐N‐acetyl‐D‐mannosaminuronic acid dehydrogenase |
|
|
|
|
|
| |
| Intracellular survival factors | Catalase katA |
|
|
|
|
|
|
| ATP‐dependent Clp protease proteolytic subunit |
|
|
|
|
|
| |
| Elongation factor Tu |
|
|
|
|
|
| |
| Superoxide dismutase |
|
|
|
|
|
| |
| Molecular chaperones | CT396 molecular chaperone DnaK |
|
|
|
|
|
|
| 60k heat‐shock protein HtpB |
|
|
|
|
|
| |
| Urease | Urease |
|
|
|
|
|
|
| Urease |
|
|
|
|
|
| |
| Urease/hydrogenase‐associated predicted GTPase |
|
|
|
|
|
| |
| Acinetobactin | ABC‐type enterochelin transport system, ATPase component |
|
|
|
|
|
|
| Streptococcal enolase | Streptococcal enolase |
|
|
|
|
|
|
| Pantothenate synthesis | Aspartate 1‐decarboxylase |
|
|
|
|
|
|
| Heme biosynthesis | Porphobilinogen synthase |
|
|
|
|
|
|
| glutamate‐1‐semialdehyde aminotransferase |
|
|
|
|
|
| |
| Acyl carrier protein |
|
|
|
|
|
| |
| T4SS effectors | Trans‐2‐enoyl‐CoA reductase (no unique name) |
|
|
|
|
|
|
not predicted; +,predicted; bold/italic, were discussed.